PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
-4.76%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(+24%)
Cap. Flow
+$260M
Cap. Flow
% of AUM
24.65%
Top 10 Holdings %
Top 10 Hldgs %
61.48%
Holding
30
New
7
Increased
14
Reduced
3
Closed
5
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$39.7M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$39.7M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$38.9M |
| 4 |
argenx
ARGX
|
$34.1M |
| 5 |
Biogen
BIIB
|
$30.8M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$54.3M |
| 2 |
Akero Therapeutics
AKRO
|
$33.1M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$20.9M |
| 4 |
Arvinas
ARVN
|
$20.5M |
| 5 |
Prothena Corp
PRTA
|
$4.52M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Akero Therapeutics
AKRO
$3.65B
| – | – |
-604,544
| Closed | -$33.1M |
|
|
27
Arvinas
ARVN
$580M
| – | – |
-599,599
| Closed | -$20.5M |
|
|
28
Prothena Corp
PRTA
$452M
| – | – |
-75,000
| Closed | -$4.52M |
|
|
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-106,210
| Closed | -$20.9M |
|
|
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-477,585
| Closed | -$54.3M |
|